TrialClinical drug investigation2023

OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agonist-Antagonist: Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics from a Phase 1 Study in Healthy Volunteers.

Yu Bagger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.